Prospective Randomized Non-Inferiority Study Comparing Natural Cycle Frozen Embryo Transfer (NC-FET) to a New Type of Endometrial Preparation for FET: Natural Proliferative Phase (NPP-FET)
NCT ID: NCT06859944
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
272 participants
OBSERVATIONAL
2024-08-05
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer
NCT06307184
Natural Cycles With Spontaneous Versus Induced Ovulation in FET
NCT03581422
Comparison of Thawing Embryos in Advance and on the Day of Transfer on Pregnancy Outcomes in FET Cycle
NCT04455191
Immediate Versus Postponed Single Blastocyst Transfer in mNC-FET
NCT04748874
PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer
NCT06074055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Thickness of the endometrium \> 7 mm on ultrasound
* Ovarian follicle \> 14 mm
* Estradiol( E2) \> 120 pg/mL Embryo transfer is scheduled on the 6th day of progesterone exposure exogenous. A progesterone dosage on the day of transfer will be systematically realized
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single transfer of frozen blastocyst in natural cycle
Embryo transfer
Frozen Embryo transfer
Natural Cycle Programmed by Progesterone
Embryo transfer
Frozen embryo transfer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Embryo transfer
Frozen embryo transfer
Embryo transfer
Frozen Embryo transfer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Testicular Sperm
* Donor oocytes
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasme University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Delbaere
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Erasme
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anne Delbaere
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRB2024108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.